Friedrich Wilhelms University Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2001
NCT00185185
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Department of Epileptology, Friedrich Wilhelms University Bonn | Department of Neurosurgery, Rheinische Friedrich-Wilhelms-University of Bonn | Medizinische Poliklinik der Friedrich-Wilhelms-Universitat, Bonn, Germany

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 3)

Cardiovascular Diseases (Phase 3)

Epilepsies, Partial (Phase 3)

Epilepsy (Phase 3)

Essential Hypertension (Phase 3)

Seizures (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5